Alissa Faris is a counsel in the Precision Medicine and Digital Health Practice Group in Haynes and Boone’s Palo Alto office.
Alissa has extensive experience in worldwide patent counseling for biotechnology clients. She focuses on preparation and prosecution in the areas of therapeutic and diagnostic humanized antibodies with application in the treatment, prevention, and diagnosis of cancer, inflammatory diseases, and neurological diseases, as well as application in the field of regenerative medicine. Alissa also has experience in preparing patentability, freedom-to-operate, non-infringement opinions and re-examinations; intellectual property due diligence reviews; and patent litigation.
Alissa has worked with a wide range of clients, including pharmaceutical companies, biotechnology companies, academic institutions, and start-ups.
- Represented a venture capital firm in the intellectual property due diligence on a target biopharmaceutical company, resulting in a $25 million series D investment in the target company.
- Prosecuted or advised on the prosecution of a variety of issued patents.
- Recognized as a “Rising Star” in Intellectual Property by Super Lawyers, Thomson Reuters, 2016-2017
J.D., Seton Hall University School of Law, 2006
B.A., Biological Sciences, University of Delaware, 1999
Intern to the Honorable Patty Shwartz, U.S. District Court for the District of New Jersey, 2005
U.S. Patent and Trademark Office
Haynes and Boone, LLP has added several patent practitioners to its Precision Medicine and Digital Health Practice Group, including Counsel Alissa Faris and Patent Attorney Michael J. Smith. San Francisco Partner Ben Pelletier also joined the team in January 2021. The Precision Medicine and Digital Health Group has also formed strategic alliances with other firms and professional advisors to fur [...]